Send2Press Newswire

PreViser Corporation Appoints Director of Medical Technology to Expand Further into Medicine

Tue, 15 Jul 2008 19:41:04 GMT

MOUNT VERNON, Wash., July 15 (SEND2PRESS NEWSWIRE) -- PreViser Corporation, a leader in oral health risk assessment and management, announced that Dr. Randy R. Nolf, DDS has been appointed as their new Director of Medical Technology. PreViser (www.previser.com) has the only patented, research-validated software that allows all dental professionals to accurately analyze patients' current oral health and future risk of oral diseases or problems. The program creates graphical reports that aid in treatment planning and enable patients to more fully participate in their treatment decisions by making their risk and disease status understandable. The PreViser suite of assessment tools has been translated into 4 languages and is accessed by dentists in over 40 countries.

PreViser is expanding this same risk assessment analysis into numerous fields of medical science, creating technology that provides decision support for medical professionals and education for patients to increase participation and compliance in their own treatments. Risk identification and management of disease in the earliest stage is sound cost saving strategy - increasingly important as patients must accept a larger share of their healthcare expenditures. When asked about PreViser's advance into medicine, Dr. Nolf stated, "We're applying important lessons learned from dentists and in dental disease management to other systemic diseases and other types of practice."

Dr. Nolf was one of the 10 periodontists on the original concept development team leading to PreViser's technology and co-holds the patent. He has maintained a full-time Periodontology practice in Stroudsburg, Pennsylvania while playing an advisory role with PreViser. "Dr. Nolf's innovative and continuing contributions to the field of disease management through computerized, objective risk and disease analysis makes it a logical progression to appoint him as the Director of Medical Technology as we expand beyond dentistry into other disease entities," stated Carl Loeb, PreViser CEO.

Nolf graduated from Temple University School of Dentistry in 1979, did his post-doctoral specialty training in the Temple Graduate Periodontology Program 1979-1981, and was a Clinical Surgical Instructor 1990-1999 in the Temple Graduate Perio Program. In his own practice, he shows a strong interest in software and technology, and is an active member of many dental associations.

When asked about the future of his practice Nolf said, "These are exciting times - medicine and dentistry are changing, and the next revolution will be in technology for less costly, interceptive treatments before expensive repair is required. Utilizing the same amount of money to treat a growing population while improving the outcomes for our patients is possible and confirmed by research. It's a great advantage to be in full-time practice while engaged in the development of these new technologies; it brings unique perspective to both my practice and my contribution at PreViser."

Nolf will continue his practice full-time with limited speaking engagements. For more information or an interview, contact Dr. Nolf through his Stroudsburg office 570-420-1500.

More information about PreViser technology: www.previser.com.

Copyright © 2008 Send2Press® Newswire, a unit of Neotrope®
TAGS: Send2Press Newswire, oral health risk assessment, PreViser Corporation

PreViser and Oral Health Innovations Ltd Form UK Partnership to Provide Oral Health Scoring and Risk Analysis

Tue, 20 May 2008 01:12:19 GMT

MOUNT VERNON, Wash., May 20 (SEND2PRESS NEWSWIRE) -- PreViser Corporation (www.previser.com), a Washington State-based provider of patented oral disease and risk assessment technology to the dental profession, announced today the finalization of a licensing agreement with Oral Health Innovations (OHI) Ltd (www.previser.co.uk) of Birmingham, England to market PreViser technology to dentists within the United Kingdom and the Republic of Ireland.

OHI Ltd is a joint venture with the University of Birmingham. Following a successful pilot, OHI will launch PreViser at a Denplan-sponsored seminar for its Excel accredited practitioners in June 2008. Discussions are also underway with a number of Primary Care Trusts on how the technology can be used as a best practice tool within National Health Service (NHS) dentistry.

Iain Chapple, Professor of Periodontology and Consultant in Restorative Dentistry, who runs an NHS referral center serving approximately six million patients, acts as adviser to OHI Ltd. Prof. Chapple commented, "PreViser is unique in its web-based approach to risk and disease scoring and has a scientific evidence base behind its efficacy. However, one of its biggest benefits is the immediate and personalized biofeedback it offers to patients. We all know that successful periodontal therapy is founded on patient education and compliance with home care regimes. PreViser is a most innovative tool that motivates patients to take personal responsibility for their own oral health.

"In addition to the obvious patient and practitioner benefits, PreViser allows oral healthcare funders to focus their resources towards those that need it most and provides a platform from which to deliver truly preventative oral care in a cost effective manner.

"As a teacher, it is exciting to be able to utilize the system, which is provided free of charge to Dental Education establishments for educational purposes. The interactive nature of the platform is something dental students actively engage in and learn from. I would encourage every dental school to take advantage of this technology."

PreViser Corporation provides web-enabled diagnostic decision support tools for dentists and dental hygienists. The PreViser Oral Health Information Suite(TM) enables quick, accurate, reproducible and objective diagnosis and analysis of oral disease risk in an easy-to-understand format for the professional and the patient.

A percentage of profits of OHI Ltd go to the Oral & Dental Research Trust of the UK and a research fellowship at the University of Birmingham.

For further information contact:

Oral Health Innovations Ltd: Liz Chapple, info@previser.co.uk

PreViser Corporation: Carl Loeb, 360-941-4715, info@previser.com

Copyright © 2008 Send2Press® Newswire, a unit of Neotrope®
TAGS: Send2Press Newswire, PreViser Corporation, decision support tools for dentists

PreViser and White Cross GmbH Partner in Germany to Provide Oral Disease and Risk Analysis

Mon, 10 Mar 2008 16:56:52 GMT

MOUNT VERNON, Wash., March 10 (SEND2PRESS NEWSWIRE) -- PreViser Corporation (www.previser.com), a Washington State-based provider of patented oral disease and risk assessment software technology to the dental industry, announced today the finalization of a licensing agreement with White Cross GmbH of Lindau, Germany, to market PreViser technology to dentists within Germany, Austria and portions of Switzerland.

White Cross will focus their marketing efforts on the over 70,000 German speaking dentists practicing in Europe. White Cross GmbH is a for-profit subsidiary company of "IHCF-Stiftung zur Forderung der Gesundheit" (www.ihcf.org), a non-profit organization that has worked to improve dental health and develop oral disease risk management programs for 20 years.

"White Cross can build on the broad contact base from educational programs organized by the IHCF foundation and its Scientific Board Members," stated Dr. Volker Scholz, a practicing dentist and member of the ICHF Scientific Board. Dr. Scholz will direct the translation effort of PreViser technology as well as supporting educational programs for PreViser users into the German language.

Dr. Werner Birglechner, dentist and Managing Director of White Cross, stated, "Dentistry in Europe, as in much of the world, is keenly interested in new methods to ensure the highest quality of care to the maximum number of patients. PreViser's disease analysis software will help dentists more accurately identify and treatment plan for patients with elevated risk or severity of oral disease." To help educate German-speaking dentists on the use of PreViser technology, White Cross will partner with praxisDienste, the leading training company in Germany for dental assistants and dental hygienists in the field of preventive dentistry. PreViser technology will be incorporated into more than 300 praxisDienste courses each year that reach over 4,000 clinical participants. "This will help to educate and integrate disease management programs into the daily work of the dental team," stated Dr. Werner Birglechner, founder of praxisDienste.

Carl Loeb, Chief Executive Officer of PreViser, noted that "White Cross is a respected leader in dentistry in Germany, Austria and Switzerland. We are very pleased to be able to partner with a firm as well respected and as well positioned as White Cross is in their market segment."

Launch of the German language version of PreViser's technology (the Oral Health Information Suite(TM)) is expected to occur during the third quarter of 2008.

PreViser Corporation provides web-enabled diagnostic decision support tools for dentists and dental hygienists. The PreViser Oral Health Information Suite(TM) enables quick, accurate, reproducible and objective diagnosis and analysis of oral disease risk in an easy-to-understand format for the dental professional and the patient.

To learn more about PreViser or to download the software for free, visit www.previser.com.

For further information contact:

White Cross: Dr. Werner Birglechner, birglechner @white-cross.info

PreViser Corporation: Carl Loeb, 360-941-4715, carlf @previser.com

Copyright © 2008 Send2Press® Newswire, a unit of Neotrope®
TAGS: Send2Press Newswire, oral disease and risk assessment software, PreViser Corporation

Previser Launches New Website and Enhanced Version of its Oral Disease and Risk Assessment Software

Mon, 24 Sep 2007 04:17:00 GMT

MOUNT VERNON, Wash. - Sept. 24 (SEND2PRESS NEWSWIRE) -- PreViser Corporation (www.previser.com), a world leader in risk and disease analysis software that enhances treatment planning for patients affected by oral disease, announced a simultaneous release of a new corporate website and a major upgrade to its software.

PreViser's version 3.0 software is now both Windows- and Macintosh-compatible, and includes improved treatment recommendations, simpler networking setup, and the ability to translate the program into non-English languages by licensing partners.

PreViser CEO Carl Loeb noted, "This major upgrade of our analytic software tools incorporates changes driven by data and feedback collected from dentists using the technology in over 26 countries worldwide. The Japanese version released there in November 2006, is widely used. Localized versions for the United Kingdom, Ireland, and Israel are coming soon."

The new version adds a new report correlating a patient's current periodontal health status to American Academy of Periodontology guidelines for treatment planning.

PreViser also released a significantly enhanced corporate website that features user-friendly learning resources, including videos and sample reports generated by the software. Customers can view specific videos showing how to easily implement PreViser tools to save time, enhance their hygiene programs, improve patients' understanding of treatment plans, and increase patient satisfaction. Videos are online at www.previser.com/demo.html.

Loeb stated, "We are very excited about our new website. It includes specific messaging for different clinical professionals within dentistry, plus new videos that simplify understanding of the effects of incorporating PreViser technology into the dental practice. We believe a dentist using our software can produce optimized clinical results, while achieving optimum productivity at the same time. Our new website significantly improves our ability to effectively bring this message to clinicians."

PreViser analytic software gives dental clinicians an easy-to-use, objective, and reproducible way to measure and communicate patients' oral disease and risk as simple numeric scores. Reports track changes over time, allowing clinicians to evaluate treatment effectiveness and outcomes. The free software generates reports on periodontal risk and disease, and risk of oral cancer, caries, tooth fracture, and root damage.

To learn more or download the software, visit www.previser.com.

Additional information, contact:
Carl Loeb
PreViser Corporation
360.941.4715
info@previser(.com)

Copyright © 2007 Send2Press® Newswire, a unit of Neotrope®
TAGS: Send2Press Newswire, PreViser Corporation, disease analysis software

The National Children's Oral Health Foundation and Previser Announce Initiative to Reduce Oral Disease Among Disadvantaged Populations

Tue, 10 Jul 2007 13:45:00 GMT

CHARLOTTE, N.C. - July 10 (SEND2PRESS NEWSWIRE) -- The National Children's Oral Health Foundation (NCOHF), www.ncohf.org, and PreViser Corporation, www.previser.com, today announced a joint initiative to collaborate in an effort to improve the oral health of low income children nationwide. The NCOHF, whose non-profit mission is to eliminate oral disease, and promote overall health and well-being for economically disadvantaged children and PreViser Corporation, the international leader in evidence-based quantification of oral disease risk will cooperate in providing PreViser analytic services to affiliate clinics of the NCOHF.

The intent of the initiative is to improve the targeting of care resources to those under-served children at greatest risk of disease based on analysis by PreViser technology.

NCOHF affiliate clinics provide care to low income children and under the announced initiative will use PreViser technology to assist in providing care most appropriate to a child's individual needs as determined by their objective PreViser risk scores.

To facilitate this process, PreViser Corporation has made a donation of $1,200,000 in assessment technology that will be utilized by NCOHF clinics.

PreViser CEO Carl F. Loeb stated "We are pleased to be able to partner with an organization that is as dedicated to oral health as the NCOHF. There is a great deal of work to be done to improve both the access to, and the quality of care for economically disadvantaged children. Oral disease is not just about cavities, but involves general health concerns that can have a great deal of impact on the degree to which children develop into their potential. We hope this grant of our technology will help the NCOHF in achieving results in this important area of our nation's health."

Fern K. Ingber, President and CEO of the NCOHF, stated "We are so appreciative of PreViser's extraordinary leadership gift. What a wonderful and valuable asset for the members of our growing national Affiliate Network. This important contribution will enable NCOHF pediatric facilities to significantly enhance their ability to serve the critical oral health needs of our nation's most vulnerable children."

PreViser Corporation, based in the state of Washington, provides web-enabled diagnostic decision support tools for dentists and dental hygienists. The PreViser(TM) Oral Health Information Suite(TM) enables quick, accurate, reproducible and objective analysis of oral disease risk in an easy-to-understand format for the dental professional and the patient. To learn more about PreViser, visit www.previser.com.

For additional information, contact:

PreViser Corporation
Carl Loeb, 360-941-4715
info@previser.com

NCOHF
Fern K. Ingber, 704-350-1600
info@ncohf.org

Copyright © 2007 Send2Press® Newswire, a unit of Neotrope®
TAGS: Send2Press Newswire, PreViser Corporatio, National Childrens Oral Health Foundation

PreViser and OralCare Corporation Partner in Japan to Provide Oral Disease Risk Assessment

Mon, 27 Feb 2006 14:00:00 GMT

MOUNT VERNON, WA (SEND2PRESS NEWSWIRE) -- PreViser Corporation (www.previser.com), a Washington State-based provider of patented oral disease and risk assessment software technology to the dental industry, announced today the finalization of a licensing agreement with OralCare Corporation of Tokyo, Japan to market PreViser technology to dentists within Japan.

OralCare will have responsibility for the translation of PreViser's assessment report language provided to patients and dentists into the Japanese language, and will focus their marketing efforts on the over 15,000 Japanese dentists that are currently customers for OralCare's extensive suite of preventive dentistry products.

Kiichi Ohtake, President of OralCare, stated, "My company has been dedicated for many years to promoting the concepts of preventive dentistry to dentists though education. PreViser's ability to identify patients that will benefit from prevention and disease management services will enhance our efforts in this area significantly. We have a natural customer base of dentists who care deeply about preventing disease, who not only help make their patients healthier, but build more successful dental practices than those clinicians not practicing preventive dentistry."

Carl Loeb, Chief Executive Officer of PreViser, noted that "OralCare is a respected leader in disease management in Japan. We are very pleased to be able to partner with a firm as well respected and as well positioned as OralCare is in their market segment."

Launch of the Japanese version of PreViser's technology (the Oral Health Information Suite(TM)) is expected to occur during the third quarter of 2006.

PreViser Corporation provides web-enabled diagnostic decision support tools for dentists and dental hygienists. The PreViser Oral Health Information Suite(TM) enables quick, accurate, reproducible and objective diagnosis and analysis of oral disease risk in an easy-to-understand format for the dental professional and the patient. To learn more about PreViser or to download the software for free, visit http://www.previser.com.

PreViser and Delta Chakir partner in Israel to Provide Oral Disease Risk Assessment

Tue, 31 Jan 2006 13:31:00 GMT

MOUNT VERNON, WA (SEND2PRESS NEWSWIRE) -- PreViser Corporation (www.previser.com), a Washington State-based provider of patented oral disease risk assessment software technology to the dental industry, announced today the finalization of a licensing agreement with Delta Chakir, Ltd., sole distributor for Kodak Dental System in Israel, to market PreViser technology to dentists and dental insurers within Israel.

Delta Chakir will have responsibility for the translation of PreViser's assessment report language provided to patients and dentists into the Hebrew language, and will initially focus their marketing efforts on dental insurers seeking to implement practical disease management strategies in the structure of new dental insurance policies.

Zvi Chakir, General Manager of Delta Chakir, stated, "The use of PreViser technology by the Israeli dental community will revolutionize oral health care in my country. We are extremely excited about the potential for coordinating the use of Kodak digital imaging equipment with PreViser's risk and disease analysis tools. We believe the marriage of these two technologies will result in streamlined treatment planning, faster claims processing by insurers, and healthier patients. This is a win-win situation for all involved."

Carl Loeb, Chief Executive Officer of PreViser, noted that "Delta Chakir is well positioned to help create a new paradigm for dentistry in Israel. We believe this venture may serve as the model for similar implantations of our technology in other nations worldwide. We are very pleased to be able to partner with Delta Chakir in this effort."

Launch of the Hebrew version of PreViser's technology (the Oral Health Information Suite(tm)) is expected to occur during the second quarter of 2006.

PreViser Corporation provides Web-enabled diagnostic decision support tools for dentists and dental hygienists. The PreViser Oral Health Information Suite(tm) enables quick, accurate, reproducible and objective diagnosis in an easy-to-understand format for the dental professional and the patient.

To learn more about PreViser or to download the software for free, visit www.previser.com.

PreViser Offers Free Oral Cancer Risk Assessment Tool as part of the Oral Health Information Suite(TM)

Mon, 28 Nov 2005 14:29:00 GMT

MOUNT VERNON, WA (SEND2PRESS NEWSWIRE) -- PreViser Corporation (www.previser.com) announces that effective November 1, 2005 it will no longer charge for use of its Internet-based tool to assess risk for oral cancer, a component of their Oral Health Information Suite(TM), software used by dental professionals worldwide.

Early detection of oral cancer is essential to a successful outcome of treatment for this serious disease," states Carl Loeb, PreViser CEO. "Once oral cancer is visible, the disease has advanced significantly. Using our tool to identify high-risk patients allows clinicians to recommend appropriate tests and exam frequency, improving the odds of catching the disease early enough for intervention. Since the dental professional is the first line of detection for this cancer, we made the decision to promote our tool's usage by offering the service free of charge in the sincere hope that it will result in earlier detection of the disease."

The OHIS(TM) Oral Cancer Risk Assessment requires no expensive or unusual testing. Most information can be provided by the patients themselves on a printed data input form while they wait, then the clinician can complete the assessment and immediately produce a printed report for the patient with a numeric score and recommendations targeted to each risk factor to prevent or detect the disease in the earliest stages.

Current users have organized special events focusing on oral cancer, offering free risk screenings to new patients. This is an effective way for dental professionals to raise consumer awareness of the importance of risk and preventive care, as well as improve the services they can offer. Recently, the tool was used at a screening event by dentists and physicians at Pocono Medical Center in Stroudsburg, PA. Dr. Randy Nolf, periodontist and PreViser co-founder, reported on his participation in that event, saying, "This was the best, most comprehensive screening I've ever participated in. The risk reports were very revealing, greater insight for the examining doctors and increased understanding for patients. This should become a routine part of every dental and medical practice."

The Oral Cancer tool is a component of the Oral Health Information Suite(TM), version 2.1, available for free download at www.previser.com. The OHIS(TM) offers a range of products in one convenient application. With version 2.1, the tools included allow dental clinicians to create accurate, objective, and quantitative reports to identify periodontal risk and disease, tooth risk (caries, fracture, and root defects), and oral cancer risk.

PreViser Corporation provides web-enabled diagnostic decision support tools for dental professionals. The PreViser Oral Health Information Suite(TM) enables quick, accurate, reproducible and objective diagnosis in an easy-to-understand format for the dental professional and the patient.

To learn more about PreViser or to download the software for free, visit www.previser.com.

Blood Clots, Heart Attacks, Strokes, Spontaneous Pre Term Births, Low Birth Weight, Rectal Cancer, Diabetes, are all Linked to Elevated C-Reactive Protein

Fri, 04 Nov 2005 14:28:00 GMT

CHICAGO, IL (SEND2PRESS NEWSWIRE) -- The first study of its kind, not only linking high C-reactive protein levels to periodontal (gum) disease but also the most effective new treatment to drastically and quickly reduce deadly C-reactive levels will be given by dentist Dr. Ron Schefdore at the prestigious Mid Winter Chicago Dental Society meeting in Feb '06. Surprisingly the study analyzed C-reactive protein blood results from top dentists throughout the country in a study to find the least painful and inexpensive treatment.

This is great news for the estimated 50% of Americans that do not go to the dentist because of fear or affordability to care. Currently people go through painful and expensive periodontal surgery, a mouth full of tooth extractions, or are taking dangerous Statin drug therapy to try and lower deadly C-reactive protein levels.

Heart attack and stroke are the biggest killers in the US; we have been focusing on the wrong indicator (cholesterol) to lower risk of a heart attack and stroke. The same bacteria in the mouth that causes calcium buildup around the teeth (tartar or calculus) were also found embedded in the calcium buildup in the arteries around the heart (arteriosclerosis) in a recent study. According to the ADA, inflamed gums affect 250 million Americans.

"Most of these people are at risk with elevated C-reactive protein levels that can easily be controlled with this new method," says Schefdore. "Afro-Americans and Hispanic Americans have the highest incidence of gum disease and - coincidently - have the highest incidence of heart disease and diabetes. Periodontal disease is now an epidemic and we need a simple, non painful and economical way for people to control this disease that can rob people of their life and good health."

People do not ever have to floss again to have healthy gums on Schefdore's program. "Be honest," he says, "do you floss correctly everyday?"

Blood tests confirmed that Schefdore's non-flossing and pain-free, inexpensive dental treatment lowers C-reactive protein levels better and faster than painful and expensive traditional dental methods, or potentially dangerous Statin drugs. It is very simple, 75% less in cost, and a lot less painful.

For information on the Chicago Dental Society Midwinter meeting, visit: http://www.cds.org/

PreViser Adds New Oral Cancer Risk Assessment Tool to the Oral Health Information Suite(TM)

Thu, 07 Jul 2005 19:55:00 GMT

MOUNT VERNON, Wash. - July 7 (SEND2PRESS NEWSWIRE) -- PreViser Corporation (www.previser.com) announces a major enhancement to their Oral Health Information Suite(tm), incorporating a new tool designed to assess risk for oral cancer.

"With a disease like oral cancer, early detection is vital for successful treatment," says Carl Loeb, CEO of PreViser. "Our technology allows dentists to easily determine oral cancer risk, while producing individualized patient risk information that can guide the decision to conduct more expensive and invasive testing if risk is found to be elevated. Applying our tool's risk assessment capability to oral cancer is a significant step in helping to prevent this serious disease."

The number of new cases of oral cancer annually exceeds 28,000 (2% of all types of cancer), and annual deaths total more than 7,000 (1% of all cancer deaths). The good news is that the likelihood of successful treatment is excellent if the disease is detected in its early stages. The bad news is that oral cancer is frequently detected only after it has progressed to an advanced stage, when the patient experiences symptoms and visual signs are readily apparent to the dentist. More bad news is that the 5-year survival rate is less than 60% and has remained unchanged for decades. PreViser's technology is designed to identify patients at elevated risk of disease, so that they can be more thoroughly examined.

"56% of all patients treated for oral cancer survive five years," reports Dr. John Martin, Chief Science Officer for PreViser. "However the percentage of patients that survive 5 years is 82% when cancer is localized, 46% when regional, and only 21% when it has spread to a distant site. Hence, preventing disease is most desirable, followed by diagnosis and treatment at the earliest possible stage."

The solution is periodic risk assessment for oral cancer, achieved through use of PreViser's software. Dr. Martin states, "This is a significant improvement in the detection and prevention of oral cancer by suggesting intervals for routine and enhanced diagnostic tests and preventive interventions based on risk, rather than waiting for the disease to become obvious."

OHIS(tm) Oral Cancer Risk Assessment requires no expensive or unusual testing; it simply gathers data about the patient's risk factors, then generates a printable report including a numeric risk score and recommendations targeted to the existing risk factors. The report informs patients of their risk of oral cancer, including what they can do to prevent or detect the disease at the earliest possible stage. Web sites are listed where a patient can acquire more information about oral cancer and its treatment. Knowing a patient's risk level enables the dentist to recommend appropriate care, such as more frequent examination or further testing with diagnostic technology specifically developed for this purpose.

The Oral Cancer Risk Assessment tool is a component of the Oral Health Information Suite(tm), version 2.1. The OHIS(tm) offers a range of products in one convenient application. With version 2.1, the tools included allow dental clinicians to create accurate, objective, and quantitative reports to identify periodontal risk and disease, tooth risk (caries, fracture, and root defects), and oral cancer risk.

PreViser Corporation provides web-enabled diagnostic decision support tools for dentists and dental hygienists.

The PreViser Oral Health Information Suite(tm) enables quick, accurate, reproducible and objective diagnosis in an easy-to-understand format for the dental professional and the patient. To learn more about PreViser or to download the software for free, visit www.previser.com.